11-74493378-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001144869.3(LIPT2):c.326G>A(p.Gly109Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000514 in 1,361,210 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G109A) has been classified as Likely benign.
Frequency
Consequence
NM_001144869.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LIPT2 | NM_001144869.3 | c.326G>A | p.Gly109Asp | missense_variant | 1/2 | ENST00000310109.5 | |
LIPT2 | NM_001329941.2 | c.326G>A | p.Gly109Asp | missense_variant | 1/2 | ||
LIPT2 | NM_001329942.2 | c.237+89G>A | intron_variant | ||||
LIPT2-AS1 | NR_171028.1 | upstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LIPT2 | ENST00000310109.5 | c.326G>A | p.Gly109Asp | missense_variant | 1/2 | 2 | NM_001144869.3 | P1 | |
LIPT2-AS1 | ENST00000526036.1 | n.13C>T | non_coding_transcript_exon_variant | 1/2 | 1 | ||||
LIPT2 | ENST00000528085.1 | c.181+89G>A | intron_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome AF: 0.00000514 AC: 7AN: 1361210Hom.: 0 Cov.: 42 AF XY: 0.00000596 AC XY: 4AN XY: 671296
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | - | The missense variant p.G109D in LIPT2 (NM_001144869.3) has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.G109D variant is novel (not in any individuals) in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. The p.G109D missense variant is predicted to be damaging by both SIFT and PolyPhen2. The nucleotide c.326 in LIPT2 is predicted conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Uncertain Significance. - |
Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | - | The missense variant p.G109D in LIPT2 (NM_001144869.3) has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.G109D variant is novel (not in any individuals) in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes.The p.G109D missense variant is predicted to be damaging by both SIFT and PolyPhen2. The nucleotide c.326 in LIPT2 is predicted conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 27, 2022 | Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals affected with LIPT2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 109 of the LIPT2 protein (p.Gly109Asp). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at